Targeting apoptotic pathway of cancer cells with phytochemicals and plant-based nanomaterials

AK Wani, N Akhtar, TG Mir, R Singh, PK Jha, SK Mallik… - Biomolecules, 2023 - mdpi.com
Apoptosis is the elimination of functionally non-essential, neoplastic, and infected cells via
the mitochondrial pathway or death receptor pathway. The process of apoptosis is highly …

[HTML][HTML] Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies

AA Rucki, L Zheng - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDA) is among the deadliest cancers in the United
States and in the world. Late diagnosis, early metastasis and lack of effective therapy are …

[PDF][PDF] MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies

GH Baek, FT Yan, Z Hu, D Cox, N Buboltz, P McCue… - Cell reports, 2014 - cell.com
KRAS mutation, which occurs in∼ 95% of pancreatic ductal adenocarcinoma (PDA), has
been shown to program tumor metabolism. MCT4 is highly upregulated in a subset of PDA …

[HTML][HTML] Role of pancreatic stellate cells in pancreatic cancer metastasis

Z Xu, A Vonlaufen, PA Phillips, E Fiala-Beer… - The American journal of …, 2010 - Elsevier
Pancreatic stellate cells (PSCs) produce the stromal reaction in pancreatic cancer (PC), and
their interaction with cancer cells facilitates cancer progression. This study investigated the …

Label-free nanoplasmonic-based short noncoding RNA sensing at attomolar concentrations allows for quantitative and highly specific assay of microRNA-10b in …

GK Joshi, S Deitz-McElyea, T Liyanage, K Lawrence… - ACS …, 2015 - ACS Publications
MicroRNAs are short noncoding RNAs consisting of 18–25 nucleotides that target specific
mRNA moieties for translational repression or degradation, thereby modulating numerous …

HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors

F Shojaei, JH Lee, BH Simmons, A Wong, CO Esparza… - Cancer research, 2010 - AACR
Molecular and cellular mechanisms underlying resistance/low responsiveness to
antiangiogenic compounds are under extensive investigations. Both populations of tumor …

MET: a promising anticancer therapeutic target

S Peters, AA Adjei - Nature reviews Clinical oncology, 2012 - nature.com
The MET pathway is dysregulated in many human cancers and promotes tumour growth,
invasion and dissemination. Abnormalities in MET signalling have been reported to …

[HTML][HTML] Combination strategies to augment immune check point inhibitors efficacy-implications for translational research

H Varayathu, V Sarathy, BE Thomas, SS Mufti… - Frontiers in …, 2021 - frontiersin.org
Immune checkpoint inhibitor therapy has revolutionized the field of cancer immunotherapy.
Even though it has shown a durable response in some solid tumors, several patients do not …

Role of pancreatic stellate cells in chemoresistance in pancreatic cancer

JA McCarroll, S Naim, G Sharbeen, J Lee… - Frontiers in …, 2014 - frontiersin.org
Pancreatic cancer is highly chemoresistant. A major contributing factor is the characteristic
extensive stromal or fibrotic reaction, which comprises up to 90% of the tumor volume. Over …

MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival

H Jin, R Yang, Z Zheng, M Romero, J Ross… - Cancer research, 2008 - AACR
The hepatocyte growth factor (HGF) and its receptor, c-Met, have been implicated in driving
proliferation, invasion, and poor prognosis in pancreatic cancer. Here, we investigated the …